Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers. by Pegtel, DM et al.
JOURNAL OF VIROLOGY, Nov. 2004, p. 12613–12624 Vol. 78, No. 22
0022-538X/04/$08.000 DOI: 10.1128/JVI.78.22.12613–12624.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Epstein-Barr Virus Infection in Ex Vivo Tonsil Epithelial
Cell Cultures of Asymptomatic Carriers
Dirk M. Pegtel,1 Jaap Middeldorp,2 and David A. Thorley-Lawson1*
Department of Pathology, Tufts University School of Medicine, Boston, Massachusetts,1 and
Department of Pathology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands2
Received 18 April 2004/Accepted 17 May 2004
Epstein-Barr virus (EBV) is found frequently in certain epithelial pathologies, such as nasopharyngeal
carcinoma and oral hairy leukoplakia, indicating that the virus can infect epithelial cells in vivo. Recent studies
of cell lines imply that epithelial cells may also play a role in persistent EBV infection in vivo. In this report,
we show the establishment and characterization of an ex vivo culture model of tonsil epithelial cells, a likely
site for EBV infection in vivo. Primary epithelial-cell cultures, generated from tonsil explants, contained a
heterogeneous mixture of cells with an ongoing process of differentiation. Keratin expression profiles were
consistent with the presence of cells from both surface and crypt epithelia. A small subset of cells could be
latently infected by coculture with EBV-releasing cell lines, but not with cell-free virus. We also detected
viral-DNA, -mRNA, and -protein expression in cultures from EBV-positive tonsil donors prior to in vitro
infection. We conclude that these cells were either already infected at the time of explantation or soon after
through cell-to-cell contact with B cells replicating EBV in the explant. Taken together, these findings suggest
that the tonsil epithelium of asymptomatic virus carriers is able to sustain EBV infection in vivo. This provides
an explanation for the presence of EBV in naso- and oropharyngeal pathologies and is consistent with
epithelial cells playing a role in the egress of EBV during persistent infection.
Epstein-Barr virus (EBV) is a ubiquitous, persistent human
herpesvirus whose tropism for B lymphocytes is well estab-
lished. However, some reports have also suggested an epithe-
lial-cell tropism for the virus based on claims of having iden-
tified EBV-infected pharyngeal epithelial cells in vivo (46).
This led many investigators to propose that the mucosal epi-
thelium of the nasopharyngeal region was the site of EBV
persistence and that the infection of B cells was not critical for
viral persistence (1, 41, 42, 61). Subsequently, however, these
findings were challenged based on the failure of other investi-
gators to reproduce them (25, 35) and the mounting body of
evidence implicating memory B cells as the site of EBV per-
sistence (4, 13, 17, 51, 52). Specifically, it has not been possible
to reproducibly detect infected epithelial cells in cross sections
of tonsils or exfoliated epithelial cells in the saliva of acutely
infected patients (25, 35). Even though these studies did not
rule out low levels of infected cells, they encouraged the belief
that EBV does not normally infect healthy epithelial cells in
vivo. Nevertheless, EBV is 100% associated with naso- and
oropharyngeal epithelial pathologies, such as nasopharyngeal
carcinoma (NPC) (3) and oral hairy leukoplakia (OHL) (18).
In NPC, the epithelial cells are predominantly latently in-
fected, whereas in OHL, an AIDS-associated lesion of the oral
epithelium, infectious virus is produced by epithelial cells in
large amounts (58). From these findings, it is clear that EBV
can latently infect and replicate in oral- and nasopharyngeal
epithelia in vivo. This raises the possibility that these lesions
may be amplified versions of infected healthy epithelium.
A recent in vitro breakthrough in understanding the infec-
tion of oropharyngeal epithelial cells was provided when 1
integrin was identified as a crucial component of the receptor
that mediates EBV infection in subsets of oral epithelial cell
lines (54). Other in vitro findings provided a mechanistic ex-
planation for this proposed dual tissue tropism (8, 10). Virions
produced by B cells in vitro have glycoprotein expression pat-
terns that favor infection of epithelial cells and vice versa. This
could result in a preferential exchange of EBV between the
tissues. If EBV in vivo is transmitted back and forth between
epithelial cells and B cells, the tissues must be in close prox-
imity to one another. Tonsil reticulated crypt epithelium (37,
38) is one such site where EBV-infected B cells are in intimate
contact with neighboring epithelium (2, 34). Great improve-
ments have been made in understanding the role of B cells in
EBV persistence in vivo due to the accessibility of infected
primary B lymphocytes in the blood and lymph nodes (51, 52)
and the availability of an in vitro infection system (26). This
work has established the importance of B cells in the tonsil
lymphoepithelium as a critical site for the establishment of
latent persistent infection and for replication of the virus (51).
In contrast, evidence that nasopharyngeal epithelial cells play
a role in EBV persistence and/or replication in healthy carriers
is still lacking.
One possible role for the epithelium in the nasopharynx is as
the first tissue that becomes infected after exposure to the
virus, because EBV is transmitted via saliva (19). Lytic repli-
cation in epithelial cells could then act as a transit route or an
amplification step prior to infection of the main target, B cells
residing in the underlying lymphoepithelium. Alternatively, ep-
ithelial cells could be used to transit and release virus, pro-
duced from infected B cells in the lymphoepithelium, back into
saliva. This kind of dual tissue tropism strategy is consistent
with the behavior of other ubiquitous herpesviruses (43), and
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in vivo evidence for such an infection route has recently
been provided for simian immunodeficiency virus in mon-
keys (50).
The failure to detect infected epithelial cells in vivo and the
lack of an accurate primary in vitro nasopharyngeal epithelial
culture model has greatly hampered research in understanding
the role these cells might play in persistence. For these rea-
sons, we set out to establish and characterize a primary tonsil
epithelial culture system that retains the heterogeneity of the
tissue found in vivo. We have developed early ex vivo tonsil
epithelial-cell cultures that express keratin markers indicative
of crypt and surface tonsil epithelia. A subset of these cells is
reproducibly infectible in vitro by coculture with EBV producer
cells. Surprisingly, evidence of EBV infection was detected prior
to the addition of exogenous virus in cultures from EBV-positive
tonsils even when maintained in the presence of acyclovir. These
observations suggest that the epithelial cells were infected ei-
ther in vivo or rapidly after explantation by virus already
present in the tissue explants. To our knowledge, these findings
are the first to describe EBV infection of healthy tonsil epi-
thelial cells derived from asymptomatic virus carriers. Our data
support the model of dual epithelial-lymphoid tropism for the
virus in vivo and the possibility that healthy tonsil epithelium in
vivo may play a role in transmission of the virus as part of the
viral life cycle and suggest that EBV can play an initiating role
in associated epithelial lesions, such as NPC and OHL.
MATERIALS AND METHODS
Primary cultures and cell lines. Tonsillectomies were performed at Massa-
chusetts General Hospital on 6- to 14-year-old patients because of obstructed-
breathing disorders. Tonsils were kept on ice in PBSAPSF (1 phosphate-
buffered saline [PBS]–0.5% bovine serum albumin–PennStrepFungizone; Gibco)
and were processed between 2 and 6 h after surgery. The epithelial culture
method we applied is a modified version of the method for culturing epidermal
keratinocytes developed by Lindberg and Rheinwald, Rheinwald and Green, and
Schon and Rheinwald (30, 40, 44). Epithelial sections of the tonsil exterior were
removed with surgical tools. Connective tissue sections of the interior were
separated from soft tissue (lymphocytes) by scraping the blunt side of a razor
blade over the tissue sections. The tissue sections were washed in cold PBSAPSF
at least 10 times, minced with razorblades, and extensively washed in cold
PBSAPSF to remove nonepithelial stroma (mostly lymphocytes) and debris. The
lymphocytes were isolated from the supernatant by Ficoll-Hypaque (Amersham
Pharmacia) centrifugation, washed two times with 1 PBS–0.5% bovine serum
albumin, and resuspended at 2  107/ml. Small explants of 1 to 2 mm3 were
resuspended in 10% fetal bovine serum (FBS)–PennStrepFungizone–Dulbecco’s
modified Eagle’s medium (DMEM)-F12–1 mM calcium (Gibco) (high-calcium
serum-containing medium), washed twice, and placed in a 100-mm-diameter dish
and incubated overnight at 37°C in an incubator (day zero). This dramatically
reduced the occurrence of fungal and/or bacterial contamination. For ex vivo
infection experiments, 0.1 mM acyclovir (UDL Labs, Rockford, Ill.) was added
to the medium. The next day, tissue sections were washed in medium again to
remove the remaining lymphocytes, and transwell devices (24-mm diameter;
Costar) were placed on top of30 to 40 explants. An inert sterile stirring magnet
was placed in the transwell for two reasons: to keep the explants attached to the
bottom of the plate and to stimulate epithelial-cell migration out of the explants.
Serum-containing medium was added in and surrounding the transwells. Three
transwells were placed in one 100-mm-diameter culture dish. The medium was
replaced on day 2. On days 3 and 4, depending on individual culture growth, the
transwells were gently removed and discarded. The medium was replaced by
defined keratinocyte serum-free medium (SFM) plus keratinoctyte growth factor
(KGF) (Invitrogen) containing 0.1 mM Ca. Most tissue explants remained con-
nected to the bottom of the plate. Fresh medium was added each day after gentle
washing. Typically, around days 7 to 10 in culture, colonies 1 cm in diameter
surround the tissue explants. If the explants were removed when the colonies
were less than 0.2 cm in diameter, further colony growth was markedly cur-
tailed. Tissue explants were gently removed by suction with a vacuum Pasteur
pipette. The serum-free culture medium was then changed every 2 days. Culture
dishes with contaminating spindle-like fibroblasts were discarded.
All cell lines were maintained under standard conditions with 5% CO2 at 37°C
in a humidified atmosphere. IB4, B95-8 (a gift of E. Kieff), BJAB, Akata, and
Daudi (all American Type Culture Collection) cell lines were maintained in
complete RPMI 1640 medium supplemented with 10% fetal bovine serum,
penicillin plus streptomycin, and L-glutamine. EBfaV-GFP (green fluorescent
protein) cells were maintained in complete RPMI with 100 g of G418 (Gibco)/
ml. EBfaV-GFP (a gift of Richard Longnecker) is a derivative of the B95-8
virus-producing cell line in which the viral LMP2 gene is replaced by a gene
cassette consisting of the enhanced-GFP gene driven by the cytomegalovirus
promoter and the neomycin resistance gene driven by the simian virus 40 pro-
moter (48).
PCR. Reverse transcription (RT)-PCR for latent genes was performed as
previously described (5, 20). Briefly, RNA was purified from 2  105 epithelial
cells and 5  106 lymphocytes using Trizol reagent (Invitrogen) as described by
the manufacturer. Lymphocytes from EBV-negative tonsils, the EBV-negative
BJAB B-cell line, and the EBV-positive IB4 B-cell line were used as controls.
cDNA was prepared as described previously (5, 20), except that the 20-l cDNA
mixture was not ethanol precipitated but brought up to 100 l with high-perfor-
mance liquid chromatography H2O and used directly. PCR was performed on
the synthesized cDNA for EBNA1U-K, EBNA1Q-K (EBNA1 from the Qp
promoter), EBNA2, LMP1 (latent form), and LMP2a. The reaction was carried
out in a final volume of 50 l in a mixture consisting of 50 mM KCl, 20 mM Tris
(pH 8.4), 2.5 mM MgCl2, 0.2 mM deoxynucleoside triphosphates, and 20 pM
(each) amplimers (final concentrations). The exception was LMP1, for which 3.0
mM MgCl2 was used. The amplimers and PCR strategies are described in detail
elsewhere (5, 20). The PCR products were visualized by Southern blotting as
described previously (33). Probes for blotting were made from PCR products
derived from the IB4 cells.
Coculture and in vitro infection. EBfaV-GFP cells and B95-8 cells were
treated with 20 ng of tetradecanoyl phorbol acetate (Sigma)/ml and 3 mM butyric
acid (Sigma) for 1 to 4 days, while Akata cells were cross-linked with 100 g of
Fab immunoglobulin G (IgG) (Jackson Laboratories)/ml overnight to induce
virus release. Cell suspensions were centrifuged (5 min at 3,000  g), and the
supernatants were filtered through a 0.45-m-pore-size filter. One milliliter of
supernatant (cell-free virus) was added to 2  105 epithelial cells in six-well
plates in 3 ml of medium. Daudi cells were incubated for 1 h in undiluted and
10-fold-diluted supernatants, washed, and placed in culture. For infection
through cell-to-cell culture, producer cells were stimulated overnight, washed,
and resuspended in SFM. Virus-releasing cells were added to six-well plates and
incubated with 1  105 to 2  105 day 7 to 10 subconfluent layers of primary
epithelial cells at a 1:1 or 2:1 ratio. Floating cells were removed at various time
points (days 1 to 3) postinfection by washes, and epithelial cells were transferred
to culture slides 4 days postinfection and prepared for staining.
Staining. Cells were cultured as described and replated at various time points
(typically days 7 to 10) in two- and eight-well chambered culture slides (Costar)
in SFM. Cytospins of IB4 (an EBV-positive cell line) and BJAB (an EBV-
negative cell line) cells were used as controls for viral-protein detection and
B-cell (CD21) and epithelial marker (Ber-ep4) expression. Cytospins and culture
slides were treated the same way in all staining procedures. For immunohisto-
chemistry (HC), cells were fixed and permeabilized for 10 to 15 min with 100%
chilled acetone. For immunofluorescence (IF), cells were fixed and permeabil-
ized for 30 min at room temperature in 4% paraformaldehyde, followed by 10
min with 0.1% Triton X-100 in phosphate-buffered saline (PBS) at 4°C. The
slides were subsequently blocked with appropriate serum for 1 h at room tem-
perature prior to indirect staining. For indirect IF staining of viral proteins, the
cells were incubated with primary monoclonal antibodies: LMP1-S12 (dilution,
1:5,000), EBNA1, viral capsid antigen (VCA), and EAD (dilution, 1:1,000) (gifts
of J. Middeldorp) and BZLF1 (dilution, 1:10) (Dako) at room temperature for
30 min and then washed three times in PBS. Secondary goat anti-mouse Alexa
488 and Alexa 594 antibodies (dilution 1:5,000) (Molecular Probes, Breda, The
Netherlands) were incubated for 1 h in the dark. The slides were washed with
PBS (three times) and examined with a fluorescence microscope (Nikon E400).
For HC and IF of cellular proteins, primary antibodies to keratin 8 (K8), K18,
K8/K18, K10, K19, K13, involucrin, fillagrin, CD21, and AE1/AE3 (pankeratins)
(Neomarkers, Fremont, Calif.) were typically diluted 1:200 and incubated for 45
min at room temperature. For HC, the slides were developed with an LSAB
detection kit (Dako) used according to the manufacturer’s instructions, and the
slides were visualized using a light microscope (Nikon TE200). For IF, the slides
were developed as described above.
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RESULTS
Culture and characterization of primary tonsil epithelial
cells. The culture process was performed in three phases. The
first culture phase, DMEM-F12 plus 10% FBS with a high (1
mM) calcium concentration, is designed to stimulate the mi-
gration and adherence of epithelial cells out of the small tonsil
tissues to the culture dish. The second phase, SFM with low
(0.1 mM) calcium plus defined KGF, ensures the elimination
of lymphocytes and fibroblasts through cell death but promotes
epithelial-cell viability and growth. In this phase, keratinocyte
growth and migration are still supported by the existing tissue
explants (40). In the third phase (SFM plus KGF), the explants
are gently removed and the epithelial cells are replated to
another dish at 60% confluency. Cells with clear epithelial
morphology started to migrate on days 3 to 5 in culture, and on
days 5 to 8, colonies of various sizes surrounded most individ-
ual tissue explants. The details are described in Materials and
Methods. Figure 1 shows a schematic and representative pho-
togaphs of the three culture phases. In general, the primary
epithelial cells remained viable for up to 4 weeks in culture.
To characterize the purity, heterogeneity, and differentiation
stage of the cultured ex vivo tonsil epithelial cells, we per-
formed HC and IF staining for epithelial and lymphoid mark-
ers. Day 7 to 8 cultures were isolated and plated at 80%
confluency on culture slides and used for staining the next day.
One hundred percent of the cells stained positive for AE1/AE3
(pankeratinocyte marker) but were completely negative for
CD21 (pan-B-cell marker) (Fig. 2A, B, and C), indicating that
the cultures were of 100% epithelial lineage. Similar results
were obtained when the cells were analyzed by flow cytometry.
The absence of keratin 10 and fillagrin expression as early as
day 7 and later (not shown) indicated that the cells had not
undergone growth arrest and were of the nonkeratinizing squa-
mous epithelial lineage (32). Individual epithelial cell types
can be distinguished based upon expression of differentiation
markers and morphology (30, 32). A subset of morphological
large epithelial cells appeared in the cultures over time (Fig. 1,
day 7 versus day 10). These cells were epithelial surface antigen
(ESA) negative (early differentiation marker [6]), involucrin
positive (late differentiation marker [56]), and keratin 13 neg-
ative (early differentiation marker) and had a large cytoplasm/
nucleus ratio (Fig. 2E, I, and J). This expression profile is con-
sistent with differentiated squamous epithelial cells (32, 56),
suggesting that a process of terminal differentiation was ongo-
ing in the cultures. Occasionally epithelial cells tended to
round up spontaneously and detach from the dish, a common
behavior of terminally differentiating primary epithelial cells in
vitro (9). Positive staining of these cells for involucrin con-
firmed that they were differentiated (data not shown).
Most epithelial tissues are complex, and individual keratin
protein expression can be used to define the origin of epithelial
cells (30). Tonsil epithelium is comprised of stratified surface
and reticulated crypt epithelia (11, 38). In situ staining of tonsil
epithelium suggests that expression of the simple epithelial
keratins K18 and K8 is limited to the crypt epithelial cells (11).
We detected variable K8 and K18 expression early in our ex
vivo tonsil cultures, suggesting that a subpopulation of epithe-
lial cells in our cultures were of crypt epithelial lineage (Fig.
2D and H). In addition, we detected variable K19 expression,
another potential tonsil crypt lineage marker (11). The variable
expression of K19 in the cultures was particularly apparent by
immunofluorescence staining compared with pancytokeratin
expression (Fig. 2A, B, F, and G) (11, 32). In summary, our
culture method produces heterogeneous squamous epithelial
cultures in which differentiation appears to be ongoing and
keratin expression patterns are consistent with those found in
tonsil epithelial cells in situ (11, 32). These results are summa-
rized in Table 1.
FIG. 1. Tonsillar explant culture scheme. Cultures were grown as described in Materials and Methods. The procedure involves three separate
steps. In step 1, tonsillar explants are placed beneath tissue culture transwell inserts. The membrane is porous, and a weight is placed on top of
the insert membrane. DMEM-F12 containing 10% FBS and 1 mM Ca2 was used during the first 4 days of culture. In step 2, the inserts are
removed and the culture medium is changed to a low-calcium defined serum-free medium with keratinocyte growth factor (Gibco). This ensures
the outgrowth of epithelial cells, abolishes fibroblast growth, and kills lymphocytes. In step 3, the explants are removed and epithelial cells are
transferred to new dishes and culture slides. Photographs of the cultures at different stages are shown. Epithelial cells begin to migrate out of the
tissue explants (T) on day 4 (d4) (black arrow). On day 7, large colonies surround the tissue explants with no visible indication of surviving
lymphocytes. On day 7, large colonies (1 cm in diameter) of cells with typical epithelial morphology surround the explants. By day 10, adherent
cells have different morphologies, some cells having acquired a very large cytoplasm-to-nucleus ratio (white arrow), often seen in differentiated
squamous epithelial cells. Thus, it appears that an active epithelial differentiation process is ongoing in the cultures.
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In vitro infection. If tonsil epithelium is important in EBV
pathogenesis, the cells should be infectible with EBV. Cocul-
ture with EBfaV-GFP-expressing EBV-producing cells (49),
but not incubation with infectious viral supernatant, resulted in
infection of all (10 of 10) independent epithelial cultures tested
(Fig. 3). This is consistent with earlier findings that cell-free
virus is usually incapable of or inefficient at infecting most
epithelial cells in vitro (16, 23, 45). The infection frequency
with EBfaV-GFP was estimated to be 0.01 to 0.5% of the
total cell population by counting GFP-expressing cells with
epithelial morphology on day 3 postinfection. To test the pos-
sibility that the titer of cell-free virus was too low, we at-
tempted to infect Daudi cells with the cell-free EBfaV-GFP
virus. We observed infection levels of up to 70% in Daudi
cells with the same cell-free virus supernatant that was unsuc-
cessful at infecting primary epithelial cells (Fig. 3C). This in-
dicates that susceptibility to infection, rather than viral titers, is
the limiting factor.
To prove that the infected cells were of epithelial origin,
they were stained for cytokeratin expression (Fig. 3B and Fig.
4A and B). True infected epithelial cells (Fig. 3A and B) could
be distinguished from occasional adherent EBV producer lym-
TABLE 1. Summary of phenotypic characterization of primary
epithelial cultures from the palatine tonsil
Marker Range ofexpression levelsa Cells
Keratins
Pankeratins / All
Keratin 19 / Subset
Keratin 8/18  Subset
Keratin 13  Subset
Keratin 10  None
Keratin 8  Subset
Keratin 18  Subset
Other
ESA  Majority
Involucrin  Subset
Fillagrin  None
CD21  None
a , clearly positive staining; , strong positive staining; , no staining.
Variable expression of specific keratins in subsets of cells indicates a heteroge-
neous population of epithelial cells derived from tonsil crypt and surface epithe-
lium.
FIG. 3. Primary tonsillar epithelial cells are susceptible to in vitro infection with EBfaV-GFP by cell-cell contact but not with cell-free virus.
(A) GFP expression could be detected in epithelial cells as early as 24 h postinfection (white arrows). Occasional adherent producer B cells are
indicated with white arrowheads. Left panels, bright field; right panels, fluorescence for the same field of cells. (B) GFP-expressing cells are
cytokeratin positive (indicated by white arrows). Left panels, red fluorescence for cytokeratins; right panels, green fluorescence for GFP expression
on the same field of cells. (C) Infection by cell-free virus was never observed with epithelial cells, but Daudi cells could be efficiently infected (36
h postinfection) with EBfaV-GFP viral supernatant; the infection efficiency was dose dependent.
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phoid cells (Fig. 3A and B) based on their extremely bright
GFP levels, morphology, and lack of keratin expression. Dual
imaging for cytokeratins and involucrin suggests that both un-
differentiated and large differentiated epithelial cells could be
infected (Fig. 4A to C).
We next tested whether latent viral proteins are expressed
and if susceptibility to infection is perhaps limited to the arti-
ficial EBfaV-GFP virus strain, which lacks LMP2 (49). We
cocultured the epithelial cells with phorbol myristate acetate-
butyric acid-stimulated B-95.8 marmoset and IgG-stimulated
Akata (not shown) cell lines and performed IF staining for
cytokeratins, EBNA1, EBNA2, LMP1, and LMP2. Both virus
strains were able to infect epithelial cells, as judged by the
detection of EBNA1 and LMP1 protein expression within the
same cells (Fig. 4D to I). EBNA2 and LMP2 expression was
not detected. These results indicate that latent genes are ex-
pressed in the EBV-infected primary tonsil epithelial cells and
that infection is not strain specific.
Ex vivo infection. During the course of characterization and
infection of the primary epithelial cells, we observed that EBV
DNA was routinely detectable in the cultures prior to infection
(data not shown). Since we employed highly sensitive PCR to
detect the viral DNA, we could not distinguish whether the
signal was derived from infected cells or from virions, virus
fragments, or cell debris from infected cells released by the
tonsil explants. To distinguish between these possibilities, we
performed RT-PCR analysis for a range of viral genes, includ-
ing EBNA1U-K, EBNA1Q-K, EBNA2, LMP1, and LMP2
genes. To our surprise, RNA for LMP1 and only LMP1 was
robustly and routinely detected in the cultures from 21 of 30
EBV-positive tonsils but in 0 out of 15 cultures from EBV-
negative tonsils. Limiting dilutions of Southern-blotted LMP1
RT-PCR products (Fig. 5) illustrate that transcript levels in
2  105 to 1  106 epithelial cells were equivalent to 10 to 100
control EBV-infected IB4 B cells. By comparison, signals for
the other genes were detected in only one or two cultures at or
close to the detection limit, casting doubt on the significance of
these findings. LMP1 is expressed both in latently infected cells
and in cells replicating the virus. However, the replicative form
is truncated and lacks exon 1. The PCR primers used were
designed to bridge exons 1 and 2 and therefore detect only the
latent form of LMP1 (53). The reproducible detection of the
latent form of LMP1 mRNA demonstrated that the primary
cultures contained latently infected cells.
It is unlikely that the LMP1 transcript signals we detected
were from viable infected B cells because the cultures were
FIG. 4. In vitro infection of primary epithelial cells. Seven- to 10-day epithelial cells were incubated in a 1:1 ratio for 1 to 3 days with viral
producer B cells stimulated to produce virus. (A and B) Merged immunofluorescence images of EBfaV-GFP-infected epithelial cells are
cytokeratin positive (red) and express GFP (green), which appears as yellow; nuclei are stained with DAPI (4,6-diamidino-2-phenylindole) (blue).
(C) Involucrin-positive cells are infected with EBfaV-GFP. (D to I) Primary tonsil epithelial cells infected in vitro with B95.8 EBV are latently
infected. Isolated cells with epithelial morphology coexpress LMP1 (red) (D and G) and EBNA1 (green) (E and H), indicating a latent stage of
infection in these cells. Nuclei are stained with DAPI (blue). Merged images (F and I) show the nuclear location of EBNA1 (light blue) and the
cytoplasmic location of LMP1.
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washed frequently with medium to remove nonadherent cells
and the epithelial cells were split twice before analysis by gently
washing them with trypsin prior to transfer to 100-mm-diam-
eter dishes. By that time, no B cells could be detected in the
cultures by histochemistry or flow cytometry. Moreover, the
tissue culture conditions were highly selective against lympho-
cytes and other nonepithelial cells. Control experiments with
primary B cells or EBV-transformed lymphoblastoid cell lines
showed that all the B cells were dead after 2 to 3 days of
culture in the selective medium (data not shown). This raised
the possibility that there were latently infected epithelial cells
in the cultures. To identify which type of cell was infected, we
performed immunochemistry and fluorescence staining to de-
tect LMP1 protein expression (Fig. 6). We chose LMP1 be-
cause the gene was the only one that we found to be repro-
ducibly expressed at the transcript level in the cultures. In
control experiments, we were able to reliably detect a single
EBV-positive LMP1-expressing cell in a background of 105
EBV-negative cells, indicating the sensitivity of this staining
(data not shown). In double-blind studies, we detected LMP1
protein expression in single cells with clear epithelial-cell mor-
phology from 5 of 19 independent 7- to 10-day-old primary
epithelial cultures. Subsequent analysis revealed that all five
FIG. 5. RT-PCR for LMP1 expression in primary ex vivo epithelial
cells from the palatine tonsil. RT-PCR was performed on RNA from
2 105 to 1 106 day 10 to 14 epithelial cells. The PCR products were
fractionated on agarose gels, Southern blotted, and hybridized with an
LMP1-specific probe. The size of the PCR product (150 bp) is indi-
cated. Limiting dilution was performed with serially diluted EBV-
positive IB4 cells as a positive control (). EBV-negative BJAB cells
and H2O were negative controls (). Epithelial cultures of 15 individ-
ual tonsils are shown; 12 were from EBV-positive donors (T), 9 of
which were positive for LMP1, and 3 were from EBV-negative donors
(T*), none of which were positive for LMP1.
FIG. 6. LMP1 protein expression in ex vivo tonsillar epithelial cells. Epithelial cells were cultured as described in Materials and Methods and
stained between days 7 and 10 with the anti-LMP1 monoclonal (S12) primary antibody for HC or IF. (A) LMP1 expression was assessed in the
EBV-positive control B-cell line IB4. (B) Epithelial-cell culture from an EBV-negative tonsil. (C and D) Epithelial-cell cultures from EBV-positive
tonsils. Left panel, low power; right panel, high power. (E and F) Epithelial-cell cultures from EBV-positive tonsils analyzed by HC (E) or IF (F).
(G and H) Epithelial-cell cultures from EBV-negative tonsils infected in vitro and analyzed by HC (G) or IF (H). Note the similarity in staining
observed when LMP1-expressing epithelial cells from an EBV-positive tonsil (ex vivo [E and F]) are compared with epithelial cells from an
EBV-negative donor infected in vitro (in vitro infection [G and H]). Panel F shows a typical epithelial perinuclear distribution of LMP1 in an ex
vivo-infected cell.
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also expressed LMP1 RNA, based on RT-PCR for latent
LMP1 transcripts, and were derived from EBV-positive tonsils,
based on DNA PCR (Fig. 6C to H), whereas 10 LMP1-nega-
tive cultures were derived from EBV-negative tonsils (Fig. 6B).
Thus, LMP1-expressing epithelial cells were found in cultures
from 5 of 9 EBV-positive tonsils and 0 of 10 EBV-negative
tonsils. The level of infection based on LMP1 protein staining
was 5 to 10 per 105 epithelial cells (0.005 to 0.01%), quite
similar to the levels of infection reported for the B-cell com-
partment (27). LMP1 (latent) transcripts were detected in all
the cultures where LMP1 protein was found. We were unable
to find evidence of EBNA1, EBNA2, or LMP2 expression in
any epithelial cells. The absence of EBNA1 may imply that the
infected cells were not proliferating (12), and this would be
consistent with the observation that the LMP1-positive cells
were always found alone, never in clusters. However, as with all
histochemical and immunofluorescence studies, it is impossible
to resolve whether the failure to find a protein represents
absence of the protein or whether the levels of expression were
too low to be detected.
One possible explanation for the presence of these infected
epithelial cells comes from the well-known phenomenon that B
cells latently infected with EBV will replicate the virus when
placed in culture. It was conceivable, therefore, that the epi-
thelial cells became infected through cell-to-cell contact with
such cells. This interpretation is unlikely, because the explant
cultures were continuously maintained in the presence of a
high concentration of acyclovir (0.1 mM) in the media. Acy-
clovir is a common antiviral agent (29) that effectively blocks
viral replication with a 50% effective dose of 0.3 M, based on
blocking viral replication in a lymphoblastoid cell line in vitro.
We conclude, therefore, that there are bona fide LMP1-posi-
tive, latently infected epithelial cells in the cultures.
Viral replication is a frequently reported consequence of
EBV infection of epithelial cells in culture which might be
differentiation dependent (10, 22, 23, 28, 47, 54). Since our
cultures were routinely grown in the presence of acyclovir, it
would not be possible to detect the presence of viral replica-
tion. Therefore, we derived epithelial cell cultures in which
acyclovir was removed after day 4. The cells were further
incubated for 4 to 6 days in the absence of acyclovir in selective
media. The epithelial cells were then stained with a cocktail
of antibodies recognizing immediate-early (BZLF1), early
(EAD), and late (VCA) viral lytic proteins. Lytic antigen ex-
pression was detected in two of two cultures from EBV-posi-
tive tonsils but in zero of two cultures from EBV-negative
tonsils (Fig. 7A to I). Most of the lytic staining was nuclear,
indicating EAD or Z protein expression, but occasional cyto-
plasmic staining (VCA) was also observed (Fig. 7B and C). The
cells expressing lytic antigens were usually found in clusters,
suggesting that the virus may have spread in the cultures
through cell-to-cell contact between epithelial cells. This is a
different pattern from what we observed with LMP1, which was
always detected only in single cells. This indicates that different
cells were expressing LMP1 and the lytic antigens. These data
show that cells in primary tonsil epithelial cultures from
healthy EBV-positive individuals probably sustain both latent
and lytic EBV infection.
DISCUSSION
The results presented in this paper relate to three important
areas of EBV interaction with epithelial cells. These are the
establishment of a representative primary culture system for a
hypothesized target of infection in vivo (tonsil epithelium), the
demonstration that a small subset of such cells is infectible in
vitro by exogenous virus via cell-cell contact, and the observa-
tion that, without adding any exogenous virus, EBV-infected
epithelial cells are already present in cultures from EBV-pos-
itive individuals.
Tonsil epithelium is a heterogeneous lymphoid organ con-
taining two different types of actively differentiating epithelia,
the lining stratified squamous epithelium and the reticulated
crypt, or lymphoepithelium. The tonsil crypts represent a spe-
cialized compartment, important in the immunological func-
tions of the tonsil because of the immediate proximity of the
epithelial and lymphoid tissues (38). Human immunodefi-
ciency virus has been reported to specifically target this region,
possibly because of the close interaction of human immuno-
deficiency virus targets (15). Keratin expression patterns con-
firmed that our procedure generated heterogeneous epithelial-
cell cultures. K8, K18, and K19 expression in subsets of cells
suggests that they were derived from the reticular crypt epi-
thelium, and the appearance of large differentiated cells was
consistent with an ongoing active process of differentiation in
the cultures (11, 32). It is possible that the patterns of keratin
expression we observed were induced in vitro. However, pri-
mary oral epithelial cells possess intrinsically determined pro-
grams for keratin expression, which are believed to be unaf-
fected by short-term in vitro culture (30). Interestingly, early
removal of the tissue explants abolished the growth and via-
bility of the remaining adherent epithelial cells. It is conceiv-
able that culturing epithelial cells from tissue explants provides
a desirable site-specific mesenchymal influence in initial stages
of culture. Mesenchymal cells are absent from cultures in
which epithelial cells are isolated from enzymatically digested
tissues. This culture procedure often requires an artificial
feeder layer, which might benefit the growth of particular sub-
populations of epithelial cells (24, 31). Our culture dynamics
support the notion that primary epithelial cells are sensitive to
their milieu (i.e., stroma), which is likely responsible for the
contextual specificity of various epithelia (37, 40).
We consistently detected EBV DNA, RNA, and proteins in
the cultures. The question arises as to the origin of these
infected cells. The obvious explanation is that we were detect-
ing contaminating infected B lymphocytes. There are several
lines of evidence that eliminate this possibility. The level of
infected B cells in the tonsil is 1 in 105 (27), so to have a
single infected cell would require the presence of 105 unin-
fected lymphocytes, which we would readily detect in the cul-
tures. Furthermore, the selective medium used in the cultures
kills all lymphocytes, including EBV-infected B cells, within a
few days. Most compelling, though, was the fact that the cells
staining positive for LMP1 and lytic proteins had the typical
morphology of epithelial cells. Indeed, the elimination of all
the lymphocytes, including EBV-infected B cells, may have
been important in increasing our chances of detecting the rare
infected epithelial cells. Where and how were these cells in-
fected? The only possibility is through contact with infected B
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cells in the explants, since the epithelial cells cannot be in-
fected by cell-free virus. Infected B cells in the explant would
have survived for only a day or two in the selective medium.
Therefore, the epithelial cells would have to have become
infected before or shortly after they began migrating onto the
tissue culture dish. Since this occurred in the presence of acy-
clovir, we must conclude that these B cells were already pro-
ducing infectious virus at the time of explantation. This in turn
leads to the inevitable conclusion that the epithelial cells were
infected by virus-producing B cells that were already replicat-
ing EBV in the tonsil. Alternatively, the epithelial cells were
already infected at the time of explantation. It is unlikely that
we will ever be able to distinguish between these two possibil-
ities, because the number of infected epithelial cells is so small
that it would be impossible to convincingly detect them on a
consistent basis in the presence of all of the lymphocytes pres-
ent when staining cross sections of intact tonsil tissue. Mech-
anistically, however, the two explanations both lead to the same
conclusion, namely, that normal tonsil epithelium is infectible
with EBV in situ (whether it occurred in vivo or in vitro), and
support the proposed dual tissue tropism of EBV for B and
epithelial cells of the crypt regions of the tonsil (8, 37, 59).
FIG. 7. (A to I) Immunofluorescence images of lytic gene expression in primary cultures from two tonsils. Cells were cultured in the presence
of acyclovir until day 4. On day 5, SFM plus KGF was added, and the cells were transferred on days 7 and 8 to culture slides. Cytospins of 8- to
16-h IgG-treated Akata cells were used as positive controls (J to M). VCA staining is cytoplasmic (J), whereas Zebra (Z) and early antigen (Ead)
staining is nuclear (K and L). Epithelial cells were fixed and stained on day 10 with the pooled monoclonal antibodies against Ead, Z, and VCA.
The antibodies were pooled to increase sensitivity (M). The white arrows in panels B and C point to cytoplasmic VCA staining. Merged images
are presented to emphasize the predominantly nuclear nature of the positive staining in both cultures derived from Z and Ead (D to L).
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The presence in our cultures of both latently and lytically
infected cells is fully consistent with their expected properties
based on the behavior of EBV in the major associated epithe-
lial pathologies, NPC and OHL, and other previous reports of
EBV-infected epithelial cells in vitro (10, 22, 47). Whether our
experiments are indicative of a role that epithelium may play in
EBV persistence remains unresolved. It might be important to
note that the frequency of EBV-infected cells in the primary
cultures was similar to that found in B cells from the same
tonsils (0.01%). An average tonsil has a total epithelial sur-
face area of 340 cm2 (37). This would represent 5  107
tonsil epithelial cells in vivo (based on the confluency of epi-
thelial cells in a 100-mm-diameter dish), which translates into
5,000 infected epithelial cells per tonsil at any given time.
This is comparable to the estimates of the total number of
infected B cells in the tonsils, which is 10,000 to 50,000 (27).
If epithelial cells do play a role in viral persistence, the
failure to infect them with cell-free virus suggests they are not
the target of primary infection. Their ability to be infected
through cell-to-cell contact means that they could mediate the
release of EBV into saliva from infected B cells in the lym-
phoepithelium. The ready ability of epithelial cells to replicate
EBV, combined with the observations that persistent infection
is not sustainable in the absence of B cells (17), further sup-
ports the idea that the primary role of epithelial cells is to
facilitate the release of EBV, not to maintain persistent infec-
tion, which is presumably the function of the B-cell compart-
ment. What, then, is the role of the latent infection we have
observed? If epithelial cells cannot sustain a persistent infec-
tion, we must conclude that latent infection is transient and
either an epiphenomenon of the ability of epithelial cells to be
infected or possibly a mechanism for short-term persistence,
which might provide a more stable source of cells producing
infectious virus.
Virion infection of polarized epithelial cells has been re-
ported, but only through the basolateral surface (54). It will be
necessary to discover conditions under which our primary ton-
sillar epithelial cells can be infected at the apical (mucosal)
surface with cell-free virus before we can speculate that the
epithelial-cell layer may also have a role as the first target
tissue in primary EBV infection.
There have been an ever-growing number of reports of suc-
cessful infection of epithelial cells in vitro. Usually, these stud-
ies have employed established cell lines (10, 14, 16, 22, 23, 28,
45–47, 49, 54, 60). Attempts to infect primary nasopharyngeal,
ectocervical, and gastric epithelia have been described, with
variable success. Nasopharyngeal tissue was reported to be un-
infectible (16); the ectocervix was reported to be infectible only
by oropharyngeal strains of EBV, not laboratory isolates (46);
and the gastric epithelium was reported to be infectible in
only 3 of 21 attempts (36). We believe, therefore, that this rep-
resents the first report of a technique to reproducibly infect
representative primary cultures from tonsil epithelium. Re-
ports of viral-gene expression patterns in infected epithelium
have also varied. For example, EBV-infected lung, colon, and
primary gastric epithelial cells probably do not express LMP1
upon EBV infection (10, 36, 46), but in other reports, EBV-
infected epithelial cells of naso- and oropharyngeal origin do
express LMP1 (10, 54). These discrepancies may in part reflect
technical issues but may also arise because epithelia from dif-
ferent sites are heterogeneous and biologically distinct. We
think, therefore, that it is important to study EBV infection in
the correct epithelial-tissue background. This concept is rein-
forced by studies of EBV in B cells, where it is clear that the
pattern of viral genes expressed is dependent upon the type
and location of the infected cell (5). It was striking that the only
latent gene we found reproducibly in the ex vivo-infected cells
was the viral oncogene LMP1. At this point, it would be pre-
mature to suggest that this reflects a novel form of EBV gene
expression, i.e., LMP1 only. This is because the lower limit of
the detection sensitivity for the RT-PCR and immunohisto-
chemistry assays for the other viral latent genes is not known
and the infected cells are so rare. This makes a negative result
difficult to interpret with confidence. Nevertheless, the pres-
ence of LMP1 suggests that it is automatically expressed upon
EBV infection of normal nasopharyngeal epithelium. Such ex-
pression of the oncogenic LMP1 could be the initiating event
that may ultimately lead to development of nasopharyngeal
carcinomas.
In vitro infection of our primary tonsil epithelial cultures
required cell-cell contact, and only a small subset of cells was
susceptible to infection. These observations are consistent with
the findings of others using different epithelial-cell types (10,
23, 54). There is increasing evidence that viruses exhibit a high
degree of specificity for their targets (7). It would be interest-
ing to see what specific characteristics the infectible cells might
have and if expression of particular viral-gene transcription
programs relates to the differentiation stage of the cells. Evi-
dence for infection specificity in epithelial cells has recently
been shown in vitro and might depend on the expression of 1
integrin (54), which is likely to correlate with the differentia-
tion stage (54, 57). Our primary in vitro model with actively
differentiating cells might prove a valuable tool to address
these issues in the future.
Early findings of EBV in oropharyngeal epithelial cells fu-
eled the notion that epithelium might play a role in viral per-
sistence (1, 45–47). However, subsequent reports were unable
to reproduce these findings (25, 35), casting doubt on the role
of epithelial cells. Recent findings in culture defining an epi-
thelial-cell receptor (8, 54) for the virus and suggesting a mech-
anism to explain the potential dual tissue tropism of the virus
for B cells and epithelial cells (8, 54) have reopened the issue.
However, what is lacking is convincing evidence of infection in
vivo. It has not been possible to detect EBV-infected epithelial
cells in vivo using EBER hybridization in combination with
B-cell and epithelial-cell-specific markers on cross sections of
tonsils and in exfoliated epithelial cells in throat washes of
infectious-mononucleosis patients (25, 35). This approach was
based on the assumption that during infectious mononucleosis
there should be a massive amount of epithelial-cell infection
that matches the levels seen in B cells, where as many as 50%
of the memory cells may be infected (21). From in vitro studies,
it is well known that most, if not all, B cells are infectible with
EBV; however, the in vitro experiments shown here and by
others (54) suggest that only a small fraction of tonsil epithelial
cells are infectible with EBV. Therefore, massive infection of
epithelial cells may not be possible in vivo during infectious
mononucleosis because, unlike B cells, most epithelial cells are
not targets of infection. This could explain the failure to detect
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infected epithelial cells in the tonsils of acute infectious mono-
nucleosis patients by using histochemical techniques.
Our findings support the developing model in which EBV is
able to infect healthy epithelium as part of its life cycle (8, 39,
54, 55) and contribute to our understanding of the evolution of
naso- and oropharyngeal epithelial pathologies.
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